Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

D8-MMAD

Copy Product Info
😃Good
Catalog No. T10947
Alias Monomethylauristatin D D8, Monomethyl Dolastatin 10 D8, Demethyldolastatin 10 D8

D8-MMAD is a deuterated form of MMAD, which is a microtubule destroyer.

D8-MMAD

D8-MMAD

Copy Product Info
😃Good
Catalog No. T10947Alias Monomethylauristatin D D8, Monomethyl Dolastatin 10 D8, Demethyldolastatin 10 D8
D8-MMAD is a deuterated form of MMAD, which is a microtubule destroyer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$971InquiryInquiry
5 mg$2,202InquiryInquiry
10 mg$4,136InquiryInquiry
50 mgInquiryInquiryInquiry
100 mgInquiryInquiryInquiry
1 mL x 10 mM (in DMSO)$3,546InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
D8-MMAD is a deuterated form of MMAD, which is a microtubule destroyer.
In vitro
MMAD (monomethyl Dolastatin 10) is coupled through a stable oxime ligation process to produce several nearly uniform antibody-drug conjugates (ADC) with a pharmacodynamic ratio of approximately 2.0. The resulting conjugate showed good pharmacokinetic properties and had strong in vitro cytotoxic activity against HER2 + cancer cells. Compared with ADCs prepared by cysteine alkylation after reduction of natural interchain disulfide bonds, site-based unnatural amino acid-based ADCs have higher cytotoxicity in vitro.
In vivo
The resulting antibody-drug conjugate (ADC) showed complete tumor regression in rodents. Their toxicological characteristics in rats have also been improved.
SynonymsMonomethylauristatin D D8, Monomethyl Dolastatin 10 D8, Demethyldolastatin 10 D8
Chemical Properties
Molecular Weight779.11
FormulaC41H58D8N6O6S
SmilesO=C(N[C@H](C1=NC=CS1)CC2=CC=CC=C2)[C@H](C)[C@@H](OC)[C@H]3N(C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C([C@@](C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])([2H])NC([C@H](C(C)C)NC)=O)=O)C)=O)CCC3
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (128.35 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2835 mL6.4176 mL12.8352 mL64.1758 mL
5 mM0.2567 mL1.2835 mL2.5670 mL12.8352 mL
10 mM0.1284 mL0.6418 mL1.2835 mL6.4176 mL
20 mM0.0642 mL0.3209 mL0.6418 mL3.2088 mL
50 mM0.0257 mL0.1284 mL0.2567 mL1.2835 mL
100 mM0.0128 mL0.0642 mL0.1284 mL0.6418 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy D8-MMAD | purchase D8-MMAD | D8-MMAD cost | order D8-MMAD | D8-MMAD chemical structure | D8-MMAD in vivo | D8-MMAD in vitro | D8-MMAD formula | D8-MMAD molecular weight